Prospective National Survey of the Palliative Situation Among Inmates in French Prisons

NCT02362295 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2015-02-24

No results posted yet for this study

Summary

PARME study had 3 objectives:

* To identify the specific number of incarcerated individuals with terminal illness in need of palliative care.
* To describe the health and penal situation of these prisoners.
* To analyse the situation of these ill prisoners especially in the context of suspended sentence for medical ground

In order to answer these questions, the investigators used a mixed method research.

Conditions

  • Critical Illness
  • Terminal Illness

Interventions

OTHER

qualitative interview

some patient are interviewed.

Sponsors & Collaborators

  • Hospices Civils de Lyon

    collaborator OTHER
  • Central Hospital, Nancy, France

    collaborator OTHER
  • University Hospital, Lille

    collaborator OTHER
  • University Hospital, Marseille

    collaborator OTHER
  • University Hospital, Toulouse

    collaborator OTHER
  • University Hospital, Bordeaux

    collaborator OTHER
  • Rennes University Hospital

    collaborator OTHER
  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER
  • Centre Hospitalier Universitaire de Besancon

    lead OTHER

Principal Investigators

  • Edouard Amzallag, Dr · Hospices Civils de Lyon

  • Sebastien Grignard, Dr · Centre Hospitalier Universitaire de Besancon

  • Blanchet Emmanuelle, Dr · CHU NANCY

  • Grimopont Frederic, Dr · CHU Lille

  • Bartoli Christophe, Dr · CHU Marseille

  • BAYLE Paule, Dr · University Hospital, Toulouse

  • Bedry Regis, Dr · University Hospital, Bordeaux

  • Bernard Benoit, Dr · CHU Rennes

  • Auger Yvain, Dr · APHP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-10-31
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02362295 on ClinicalTrials.gov